Literature DB >> 11201632

Reversible sympathetic vasomotor dysfunction in POTS patients.

J Freitas1, R Santos, E Azevedo, O Costa, M Carvalho, A F de Freitas.   

Abstract

BACKGROUND: Orthostatic intolerance refers to the development upon assuming an upright posture of disabling symptoms, which are partly relieved by resuming the supine position. Postural tachycardia syndrome (POTS) is an orthostatic intolerance syndrome characterized by palpitations due to excessive orthostatic sinus tachycardia, lightheadedness, tremor, and near-syncope. Patients usually undergo extensive medical, cardiac, endocrine, neurological and psychiatric evaluation, which usually fails to identify a specific abnormality. We investigated the autonomic and hemodynamic profile of POTS patients and the efficacy of bisoprolol and or fludrocortisone. METHODS AND
RESULTS: We evaluated eleven female patients with POTS before and after medical treatment with a cardio-selective beta blocker (bisoprolol) and/or fludrocortisone, and eleven age-matched controls. Variability of heart rate and systolic blood pressure was assessed by Fast Fourier Transform, and spontaneous baroreceptor gain by temporal sequences slope and alpha index. Modelflow was used to quantify hemodynamics. All patients improved greatly after medication. The autonomic and hemodynamic impairment observed in patients with POTS, particularly after orthostatic stress, is treated effectively with bisoprolol and/or fludrocortisone. These results need further confirmation in a controlled double-blind study.
CONCLUSIONS: Proper medical treatment dramatically improves the clinical and autonomic/hemodynamic disturbances observed in patients with POTS. The data support the hypothesis that POTS is due to a hyperadrenergic activation and/or hypovolemia during orthostasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11201632

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  4 in total

1.  Diagnosis and management of postural orthostatic tachycardia syndrome: A brief review.

Authors:  Howraa Abed; Patrick A Ball; Le-Xin Wang
Journal:  J Geriatr Cardiol       Date:  2012-03       Impact factor: 3.327

2.  Bisoprolol, Known to Be a Selective β₁-Receptor Antagonist, Differentially but Directly Suppresses IK(M) and IK(erg) in Pituitary Cells and Hippocampal Neurons.

Authors:  Edmund Cheung So; Ning-Ping Foo; Shun Yao Ko; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

Review 3.  Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Daniel Missailidis; Sarah J Annesley; Paul R Fisher
Journal:  Diagnostics (Basel)       Date:  2019-07-20

4.  Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis.

Authors:  Joel Swai; Zixuan Hu; Xiexiong Zhao; Tibera Rugambwa; Gui Ming
Journal:  BMC Cardiovasc Disord       Date:  2019-12-30       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.